company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4711000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4711000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,130000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,71000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,799000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-162000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3873000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3873000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,10000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,15000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,14122000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,14147000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,14117000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10235000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6013000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6013000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,129000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,63000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,769000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3201000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8253000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8253000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2010000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7200000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5186000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5186000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,23000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3044000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6845000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6845000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,128000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,29000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,679000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-251000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6260000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6260000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-18000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1025000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11385000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10342000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10342000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,23000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,19000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,19000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4101000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6282000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6282000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,125000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,17000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,792000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,416000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4932000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4932000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5200000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,102000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5299000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5299000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,20000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,16000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,16000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,383000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5489000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5489000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,120000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,13000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,663000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,275000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4418000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4418000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1000000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1000000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1000000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3414000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5160000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5160000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,121000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1080000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,374000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3582000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3582000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1000000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,998000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,998000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,8000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,8000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,9073000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,51000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-47000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9093000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9077000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6493000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6886000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6886000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,83000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1914000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-891000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5780000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5780000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,-103000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-102000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-102000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5882000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3887000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3887000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,67000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-791000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-711000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5322000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5302000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,-160000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-160000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-160000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5462000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3807000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3807000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,42000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,255000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-189000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3699000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3699000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-88000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,-160000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-247000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-247000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3947000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3591000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3591000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,33000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,272000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1013000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4307000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4307000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,86000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,-349000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,14722000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,14459000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,14459000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10152000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4738000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4738000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,31000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,485000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-455000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4669000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4669000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,-558000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,27679000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,27120000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,27120000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,22448000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6090000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6090000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,31000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,9000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,533000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1055000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4462000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4462000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9331000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9336000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9336000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,1067000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1066000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-2200000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3527000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1327000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1327000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12471000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8961000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8961000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,31000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,46000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,560000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,722000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7602000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7602000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-616000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-628000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-628000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-101000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-345000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,37378000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5768000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,42700000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,42700000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,34470000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8308000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8308000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,47000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,50000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,793000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1263000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6155000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6155000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-521000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2003000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2000000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-524000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-524000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,99000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-118000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-176000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1012000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,817000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,817000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5862000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9455000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9455000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,57000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,53000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,787000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,505000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8053000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8053000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-358000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-358000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-358000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-119000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,850000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-65000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1352000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2016000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2016000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6395000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11918000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11918000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,71000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,64000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2289000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-17000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9511000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9511000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-202000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-21004000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2115000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-19091000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-19091000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-216000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-25000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,324000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,82000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,82000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-28520000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12481000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12481000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,101000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,86000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1605000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2020000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12709000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12709000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-105000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3674000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7601000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3822000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3822000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,81070000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,121000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,81189000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,81189000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,72302000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12719000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12719000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,112000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,113000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1819000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,815000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9860000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9860000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-271000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-52522000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7000000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-45793000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-45793000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-251000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-251000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-55904000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11365000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11365000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,133000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,198000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,821000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1548000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11761000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11761000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-283000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6910000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10000000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2807000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2807000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,581000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,581000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8373000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12823000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12823000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,157000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,195000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1751000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2135000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12855000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12855000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-90000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2946000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11213000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8177000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8177000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-65000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,36000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-29000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-29000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4707000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13485000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13485000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,160000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,165000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1812000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1689000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9659000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9659000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-177000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12057000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,11880000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,11880000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-67000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,31000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-36000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-36000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2185000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12903000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12903000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,167000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,106000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1693000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,502000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10435000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10435000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-102000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8650000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8548000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8548000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-67000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,44000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-23000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-23000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1910000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,822000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,822000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,172000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,100000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1767000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1885000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4746000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4746000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-39000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2800000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2761000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2761000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-69000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,49186000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1889000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,51006000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,51006000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,58513000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15057000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15057000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,176000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,74000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1827000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4666000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17646000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17646000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,30000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16720000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16750000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16690000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-74000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,57000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-17000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-17000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-973000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21471000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21471000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,192000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,18000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5789000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1243000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14229000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14229000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8905000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-73000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,58000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,304000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,289000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,289000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5035000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14530000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14530000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,191000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1668000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,785000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11884000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11884000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1175000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1175000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1175000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-78000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,69000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-9000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-9000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10718000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14926000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14926000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,187000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1586000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1653000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11500000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11500000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-106000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1400000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1294000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1294000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-78000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,53832000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5140000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,58894000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,58894000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,48688000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,42000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20095000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20095000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,169000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1612000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3567000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14747000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14747000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-14000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-14000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-81000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,81000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,9591000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9591000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9591000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5170000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12150000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12150000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,37000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1220000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-579000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11472000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11472000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,97000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,93000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,93000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,38000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,37000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,37000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11342000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,9000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:32:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10974000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:32:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10974000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:32:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,35000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:32:34+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-181000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:32:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1033000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:32:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3270000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:32:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13357000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:32:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13357000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:32:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:32:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-35485000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:32:34+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,8000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:32:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:32:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-35481000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:32:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-35481000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:32:34+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:32:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1611000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:32:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1605000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:32:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1605000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:32:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-47233000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11176000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11176000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,32000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-172000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,922000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,421000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9973000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9973000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,3000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,23350000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,23345000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,23345000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2314000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2314000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2314000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,15686000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11133000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11133000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,27000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-24000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,995000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-706000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10841000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10841000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8961000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12500000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3539000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3539000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,29000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,29000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,29000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7273000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23232000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23232000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,26000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,5000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12576000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,298000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10327000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10327000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-55000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6250000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6195000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6195000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,6000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,11537000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,9000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,11552000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,11540000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7408000.0
